Meg Gonsalves
Postdoctoral Clinical Pharmacologist
Meg Gonsalves is a Postdoctoral Clinical Pharmacologist at A2-Ai. Leveraging her PhD in Neuroscience from Brown University, she blends scientific understanding with business operations to manage complex projects and support data-driven decisions that accelerate clients' drug-development programs.
newest
blog
Handling of Missing Covariates
April 30, 2026
blog
Modeling Monday, Part 2: Fixed vs. Mixed Effects Modeling—From Naïve Pooling to Population Pharmacokinetics
March 9, 2026
research spotlights
Mapping the Psychedelic Brain: What Intravenous DMT Reveals About Neurochemistry and Cortical Dynamics
February 18, 2026
blog
Modeling Monday, Part 1: Noncompartmental Analysis as the Foundation of Pharmacokinetic Insight
February 9, 2026
research spotlights
From Mouse to Horse to Human: What Metronidazole Can Teach Us About Translating Pharmacokinetics Across Species
January 20, 2026
updates
A Year of Science at A2-Ai: Reflections from 2025
December 26, 2025
news
New FDA Guidance on QTc Labeling: What Drug Developers Need to Know
December 8, 2025
research spotlights
Aligning Clinical Trials with Real-World Aging Trends
November 20, 2025